n-hydroxysuccinimide s-acetylthioacetate has been researched along with daunorubicin in 1 studies
| Studies (n-hydroxysuccinimide s-acetylthioacetate) | Trials (n-hydroxysuccinimide s-acetylthioacetate) | Recent Studies (post-2010) (n-hydroxysuccinimide s-acetylthioacetate) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
|---|---|---|---|---|---|
| 29 | 0 | 14 | 8,239 | 886 | 1,310 |
| Protein | Taxonomy | n-hydroxysuccinimide s-acetylthioacetate (IC50) | daunorubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belliot, SO; Crommelin, DJ; Haisma, HJ; Smit, RH; Storm, G; Vingerhoeds, MH | 1 |
1 other study(ies) available for n-hydroxysuccinimide s-acetylthioacetate and daunorubicin
| Article | Year |
|---|---|
Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Binding Sites; Carcinoma; Cross-Linking Reagents; Daunorubicin; Drug Carriers; Female; Glucuronates; Glucuronidase; Humans; Imidoesters; Immunoglobulin Fab Fragments; Liposomes; Mice; Ovarian Neoplasms; Prodrugs; Succinimides; Sulfides; Tumor Cells, Cultured | 1996 |